Abstract
Global pharmaceuticals industry is expected to reach $1.5 trillion by 2021 with a moderate growth of 4%-7% although it was almost 9% in the recent past (IMS, 2016). This changes in the regular growth projection is due to some basic transformation in this sector among which gradual reduction of blockbuster era, innovation crisis, requirement of high R&D investment, reduced health budget by many governments, emergence of biosimilars and traditional medicines, uneven price competition, drug approval stagnation, institutional buying, strict regulatory guidelines are important. Nevertheless, Bangladesh pharmaceuticals industry is now a promising global player with a domestic market size of $2 billion (BAPI, 2017). This sector is exporting medicines to 127 countries including USA, UK and other regulated countries with a global market capitalization of almost $ 82.11 million after meeting 98% of the local demands. The average growth in domestic and export markets are 15% and 24% respectively (The Daily Star, 2017 & BAPI, 2017). Although this industry seems to be very flourishing both in domestic and global market but it is highly dependent on other countries considering researches and technologies that would be major setbacks in the upcoming days. Therefore, this study illustrates the contemporary transforming in global pharmaceuticals industry & suggests some strategic imperatives for Bangladesh enterprises.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
